Pharmagreen Biotech Inc. (PHBI)

Revenue by Product

Financials in millions USD. Fiscal year is October - September.

Fiscal Year	FY 2024	FY 2023
Period Ending	Sep 30, 2024	Sep 30, 2023
Cannabis Biotech Complex	3.41K
Cannabis Biotech Complex Growth	13.74%

Revenue by Geography

Financials in millions USD. Fiscal year is October - September.

Fiscal Year	FY 2024	FY 2023
Period Ending	Sep 30, 2024	Sep 30, 2023
United States	3.41K
United States Growth	13.74%